Lilopristone

Drug Profile

Lilopristone

Alternative Names: ZK 98734

Latest Information Update: 12 Feb 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer Schering Pharma
  • Class Abortifacients; Antineoplastics; Antiprogestogens; Estrenes
  • Mechanism of Action Glucocorticoid receptor antagonists; Progesterone receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Induced abortion; Pregnancy

Most Recent Events

  • 12 Feb 2015 Discontinued - Clinical-Phase-Unknown for Induced abortion in USA (unspecified route) prior to February 2015
  • 12 Feb 2015 Discontinued - Preclinical for Pregnancy (Prevention) in India (unspecified route) prior to February 2015
  • 14 Aug 2001 No-Development-Reported for Induced abortion in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top